Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in randomized data from the interactions of atorvastatin and clopidogrel (INTERACTION) trial

被引：0
|
作者：
Serebruany, VL
Midel, MG
Malinin, AI
Lowry, DR
Oshrine, BR
Steinhubl, SR
O'Connor, CM
Hennekens, CH
机构：
[1] Sinai Hosp, Thrombosis Res Ctr, Baltimore, MD USA
[2] Univ N Carolina, Chapel Hill, NC 27514 USA
[3] Duke Univ, Clin Res Inst, Durham, NC 27710 USA
[4] Univ Miami, Miami, FL 33152 USA
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)93725-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] Interaction of proton pump inhibitors (PPIs) with the antiplatelet effect of clopidogrel in patients undergoing coronary stenting
    Zuern, C. S.
    Geisler, T.
    Lutilsky, N.
    May, A. E.
    Herdeg, C.
    Winter, S.
    Schwab, M.
    Gawaz, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 444 - 444
  • [22] CLINICAL SIGNIFICANCE OF THE TREATMENT TIMING OF CLOPIDOGREL IN PATIENTS UNDERGOING CORONARY STENTING
    Chen, I. C.
    Chao, T. H.
    Chang, Y. T.
    Kao, Y. H.
    Tsai, H. S.
    Li, Y. H.
    Lin, L. J.
    Tsai, L. M.
    Chen, J. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 167 - 168
  • [23] The antiplatelet response to clopidogrel in diabetic patients undergoing elective coronary stenting
    Bliden, K. P.
    Lawal, L.
    Singla, A.
    Yadav, S.
    DiChiara, J.
    Antonino, M. J.
    Tantry, U. S.
    Saucedo, J. F.
    Gurbel, P. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 897 - 898
  • [24] Pharmaco-epidemiological study of the interaction between atorvastatin and clopidogrel following percutaneous coronary interventions
    Brophy, J
    Costa, V
    Babapulle, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 50A - 50A
  • [25] Omeprazole and atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation in patients undergoing percutaneous coronary intervention in a tertiary health care system: A prospective drug-drug interaction study
    Nagavi, Jinesh Bahubali
    Gurupadayya, Bannimath
    Anantharaju, Preethi Gotadake
    IJC METABOLIC & ENDOCRINE, 2016, 13 : 35 - 40
  • [26] Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes
    Mitsios, JV
    Papathanasiou, AI
    Rodis, FI
    Elisaf, M
    Goudevenos, JA
    Tselepis, AD
    CIRCULATION, 2004, 109 (11) : 1335 - 1338
  • [27] Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary Stent thrombosis
    Wenaweser, Peter
    Windecker, Stephan
    Billinger, Michael
    Cook, Stephane
    Togni, Mario
    Meier, Bernhard
    Haeberli, Andre
    Hess, Otto M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (03): : 353 - 356
  • [28] Impact of Anemia on Platelet Response to Clopidogrel in Patients Undergoing Percutaneous Coronary Stenting
    Toma, Catalin
    Zahr, Firas
    Moguilanski, Diego
    Grate, Sheree
    Semaan, Roy W.
    Lemieux, Nicole
    Lee, Joon S.
    Cortese-Hassett, Andrea
    Mulukutla, Suresh
    Rao, Sunil V.
    Marroquin, Oscar C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (08): : 1148 - 1153
  • [29] Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial
    Parizi, Mohammadjavad Mehdizadeh
    Vafa, Reza Golchin
    Ahmadi, Amin
    Heydarzade, Reza
    Sadeghi, Mehrdad
    Khademolhossseini, Amin
    Amiri, Farhang
    Mansorkhani, Soroush Khoshnood
    Tavan, Ali
    Hosseini, Nazanin
    Montaseri, Mohammad
    Hosseini, Seyed Ali
    Kojuri, Javad
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2023, 2023
  • [30] Platelet inhibition with prasugrel (CS-747) versus clopidogrel in patients undergoing coronary stenting: The subset from the JUMBO trial
    Serebruany, Victor L.
    Midei, Mark
    Meilman, Henry
    Malinin, Alex
    Lowry, David
    CIRCULATION, 2006, 114 (18) : 813 - 814
12345